ÀÌÀº¿ì (1997). Åëdz ´Ù½º¸®±â: Àß ¸Ô°í Àß ¸¶½Ã´Â ³²ÀÚ°¡ Àß °É¸®´Â º´, ¼­¿ï, û»ê ÃâÆÇ»ç.

Âü°í¹®Çå : °í¿ä»êÇ÷Áõ°ú ÅëÀV¿¡ ´ëÇÑ ¿Ã¹Ù¸¥ ÀÌÇØ, »ïÀÏÁ¦¾à

Adams, PF, Hendershot, GE, & Marano, MA, Centers for Disease Control and Prevention/National Center for Health Statistics (1999) . Current estimates from the National Health Interview Survey 1996. Vital Health Stat 10, 200 , 1-203.

Becker, MA, & Chohan, S. (2008). We can make gout management more successful now, Curr Opin Rheumatol. 20 (2): 167-72.

Bull, P. W., Scott, J. T. (1989). Intermittent control of hyperuricemia in the treatment of gout. J. Rheumatology, 16: 1246-1248.

Choi, HK, & Curhan, G (2007). Alcohol and gout, Am J Med, 120 (10): e5.

de Klerk, E, van der Heijde, D, Landewe, R, van der Tempel, H, Urquhart, J, & van der Linden, S. (2003). Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout, J Rheumatol. 30 (1): 44-54. Erratum in: J Rheumatol. 2003, 30(2): 423.

Friberg, F, & Scherman, MH. (2005). Can a teaching and learning perspective deepen understanding of the concept of compliance? A theoretical discussion, Scand J Caring Sci, 19 (3): 274-9.

Hong, YH, & Lee, CK (2005). Management of gout, Korean J Med, 69 (4): 459-462.

Kim SY, De Vera MA, Choi HK. (2008). Gout and mortality, Clin Exp Rheumatol, 26 (5 Suppl 51): S115-9.

Meiner, SE (2001). Gouty arthritis: not just a big toe problem, Geriatr Nurs. 22 (3), 132-134.

Riedel, AA, Nelson, M, Joseph-Ridge, N, Wallace, K, MacDonald, P, & Becker, M (2004). Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol, 31 (8): 1575-81.

Russel,l CL, & Conn, VS. (2005). Editorial: medication management among adults with chronic illness, West J Nurs Res. 27 (5): 531-533.

Saag, KG, & Choi, H. ( 2006). Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther , 8 Suppl 1:S2.

Schumacher, HR, & Chen, LX (2008). The practical management of gout, Cleve Clin J Med, 75 Suppl 5: S22-5.